StockTipsArenaBeta

BUY Ajanta Pharma Limited — Kush Bohra

BUYAjanta Pharma Limited

byKush BohraHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via NDTV Profit (Live)

Entry₹3,691.1Inferred
Target₹3,860
Total upside +4.58% (call closed)
Stop loss₹3,590-2.74% risk
Exit₹3,59024 Aug 2026, 9:20 am
Stop-loss hit-2.74%
Follow Kush Bohra for new calls(41% target hit, 88 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 126 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Aug 2026
2 supporting3 opposing
Supports the BUY call (2)

Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore

NewsGoogle News·14 Aug · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·7 Jul · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह

NewsGoogle News·5 Aug · 3w ago

(opens in new tab)

Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!

NewsGoogle News·5 Aug · 3w ago

(opens in new tab)

Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!

NewsGoogle News·5 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.